Biotechnology

#Biotechnology #Pharma #Pharmacovigilance #Regulatory

FDA vs EMA: biotechs & the challenges of international pharmacovigilance

Biotechs involved in drug discovery have to navigate increasingly complex regulatory environments across borders. Experienced experts and non-executive advisors to Arriello, Eric Caugant in Paris and Judi Sills in New Jersey highlight the main differences between US and EU requirements, and advise on best preparations. Small biotech companies are commanding… Read More

#Editor's Choice #Exclusive Content #News #Regulatory

#AI / data analytics / healthtech / informatics #Biotechnology #Pharmaceuticals #Technology

AI-powered indication expansion partnership entered

Healx has partnered with Ono Pharmaceutical to leverage Healx’s indication expansion technology to identify new disease indications with high unmet needs that could be treated by Ono’s assets. Healx’s AI drug discovery platform, Healnet, integrates data from multiple sources – including biomedical research, patient insight, scientific literature and curated proprietary… Read More

#News

#Biomedicine #Biotechnology #Events #Lab automation #Screening #SLAS #SLAS 2021

SLAS partners with AseBio and sponsors BioSpain 2021

The Society for Laboratory Automation and Screening (SLAS) has partnered with Spanish Bioindustry Association (AseBio) to support the intersection of economic, technological and business areas of biotechnology and biomedicine. As part of this partnership, SLAS will support BioSpain 2021 as a sponsor between September 27 and October 1, 2021 in… Read More

#News #Trending News

#Biotechnology #Clinical trials #Data #Microbiology #Pharmaceuticals

Cardiac patients receiving nasal gel showed reduction of S. aureus

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel medicines that can prevent life threatening infections, has released data from its recent Phase IIb clinical trial. In March 2021, the company announced that this study had met its primary endpoint, demonstrating a reduction of 2.5 log… Read More

#News

#Biologics / Biotechnology #Biotechnology #Covid-19 #Life sciences #Public health

Europe’s emerging biotechs: Challenges, opportunities and funding

Listen to this article on the DDW Podcast: John Macdonald is Vice President, Venture & Financial Alliances at ICON. He examines the European biotech sector – its expertise and opportunities and potential for growth. By harnessing biological processes on a cellular and biomolecular level, biotech is benefitting industries as varied as… Read More

#Business & Investment #Covid-19 #Editor's Choice #Exclusive Content #Market Reports #News #Opinion

#Assays #Biotechnology #Life sciences #Therapeutics

PerkinElmer expands KRAS oncology drug discovery assays

PerkinElmer has released four new ready-to-use AlphaLISA KRAS kits, designed to help scientists better understand complex KRAS protein structures and mutations so they can more easily, quickly, and precisely identify potential new therapeutic candidates for a wide range of prevalent cancers. Researchers will now be able to choose between PerkinElmer’s… Read More

#News

#Biotechnology #Biotherapeutics #Market reporting

Innovation and opportunity within Europe’s biotech sector

Listen to this article on the DDW Podcast: Lu Rahman introduces a slice of European biotech expertise Thanks to the Covid-19 pandemic, the global biotech sector has been thrown into the spotlight, not just in the drug discovery and development word, but as a sector that the general public has come… Read More

#Editor's Choice #Exclusive Content #Intelligence #Market Reports #News #Opinion #Trends & Analysis

#Awards #Biopharmaceuticals #Biotechnology #Clinical trials

Frost & Sullivan announces DCT award winner 

Thread, a technology and service provider for decentralised clinical trials, has been awarded a Frost & Sullivan award. The company scooped the Frost & Sullivan’s 2021 Customer Value Leadership Award in the decentralised clinical trials industry. “Thread’s innovations via its decentralised trials platform are sure… Read More

#News

#Bioscience #Biotechnology #Cell and gene therapy #Cell and Gene Therapy Catapult #Drug development #Life sciences #Research

GSK unveils plan for one of Europe’s largest life science campuses

GSK has announced that it planning to develop its research & development site in Stevenage, UK,  into one of Europe’s largest clusters for biotechnology and early-stage life science companies. The concept has been developed in partnership with Stevenage Bioscience Catalyst (SBC), among others and would build on GSK’s existing presence,… Read More

#News

#Biopharmaceuticals #Biotechnology #Drug development #Investment #Pharmaceuticals #Therapeutics

New laboratory boosts high-potency drug development

US-based Continuus Pharmaceuticals has opened a new laboratory space and new technology to help the development of high-potency drugs. The new lab and technology are the latest developments in Continuus’ ongoing expansion, coming six months after receiving a US$69.3 million US government contract for the domestic production of medicines. “Our… Read More

#News

#Automated workflows #Biotechnology #Life sciences #Research #Webinar

Multimodal zebrafish workflows on a confocal imaging reader: webinar

Join this BioTek webinar to learn how quantitative phenotypic analysis is central to many zebrafish research workflows. Phenotypic analysis often involves leveraging multiple technologies for molecular, cellular and organismal-level evaluations. Accordin to Biotek, the new Cytation C10 confocal imaging reader is a powerful single-instrument solution for multimodal plate reading,… Read More

#News

#Biotechnology #DNA #Drug development #Drug discovery

Pioneering DNA-encoded chemical library technology

As an expert in DNA-encoded chemical library (DEL) technology, X-Chem has set up a free-to-register, interactive virtual booth to display how it efficiently unlocks possibilities in small molecule drug discovery and development. The booth includes information about X-Chem, a video library, brochures and insert sheets on mechanical chemistry,… Read More

#News

#Awards #Biotechnology #Pharmaceuticals

Biotech company win Tech-Xpo 2021

Ferryx won ‘Best Elevator Pitch’ at SETsquared Bristol’s Tech-Xpo. Tech-Xpo is a flagship pitch, demo, connect showcase, providing a platform for start-ups to showcase their innovative technologies and raise investment in Bristol, UK. Founded in 2019 as a spin-out from the University of Bristol, Ferryx is dealing with the lack… Read More

#News #Start-up Zone

#Biopharmaceuticals #Biotechnology #Covid-19 #Health #Life sciences

UK pharma sees R&D spend hold up despite Brexit and Covid-19

A survey of 75 pharmaceutical, life sciences and medtech businesses indicates R&D spending is being maintained and is set to rise in 2021, despite Brexit and the impact of Covid-19. The survey included SMEs in these sectors in the UK and was conducted by accountancy group MHA. This is positive… Read More

#Business & Investment #News #Trending News #Trends & Analysis

#Biotechnology #Biotherapeutics #Clinical trials #Therapeutics

Starton Therapeutics features on Amazon Prime ‘Unicorn Hunters’

‘Unicorn Hunters’ is a new show on Amazon Prime which invites viewers around the world to invest alongside a panel of entrepreneurs and business leaders. It aims to level the field for start-ups who do not have access to traditional venture capital funding. The panel includes Steve Wozniak (Co-founder of… Read More

#News

#Biologics / Biotechnology #Bioscience #Biotechnology #Drug delivery #Drug development #Drug discovery

Switzerland: punching above its weight as global biotech hub

Listen to this article on the DDW Podcast:   To understand Switzerland’s continued success in the biotech sector and gain personal insights, Lu Rahman spoke to Michael Altorfer (CEO of the Swiss Biotech Association), Jan Lucht (Head of Biotechnology, scienceindustries), Claude Joris (Secretary General, BioAlps), and Carole Delauney (Business Development Director… Read More

#Editor's Choice #Exclusive Content #Market Reports #News